Recent executive action has accelerated federal marijuana rescheduling under the Controlled Substances Act. Following President Trump’s December 2025 executive order directing expedited movement to Schedule III, the Department of Justice in April 2026 issued a final order immediately placing FDA-approved marijuana products and state-licensed medical marijuana into Schedule III, effective April 28. This partial step leaves broader rescheduling—including non-medical forms—subject to a new expedited DEA administrative hearing that begins June 29, 2026, and must conclude by July 15. The hearing outcome will determine whether formal rulemaking advances the full shift from Schedule I, directly shaping timelines for banking access, tax treatment under 280E, and research expansion while preserving controls on illicit trafficking.
Polymarket 데이터를 참조하는 실험적 AI 생성 요약입니다. 이것은 거래 조언이 아니며 이 마켓의 정산에 영향을 미치지 않습니다. · 업데이트$764,577 거래량
6월 30일
2%
12월 31일
27%
$764,577 거래량
6월 30일
2%
12월 31일
27%
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
마켓 개설일: Feb 7, 2026, 5:04 PM ET
Resolver
0x65070BE91...The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
Resolver
0x65070BE91...Recent executive action has accelerated federal marijuana rescheduling under the Controlled Substances Act. Following President Trump’s December 2025 executive order directing expedited movement to Schedule III, the Department of Justice in April 2026 issued a final order immediately placing FDA-approved marijuana products and state-licensed medical marijuana into Schedule III, effective April 28. This partial step leaves broader rescheduling—including non-medical forms—subject to a new expedited DEA administrative hearing that begins June 29, 2026, and must conclude by July 15. The hearing outcome will determine whether formal rulemaking advances the full shift from Schedule I, directly shaping timelines for banking access, tax treatment under 280E, and research expansion while preserving controls on illicit trafficking.
Polymarket 데이터를 참조하는 실험적 AI 생성 요약입니다. 이것은 거래 조언이 아니며 이 마켓의 정산에 영향을 미치지 않습니다. · 업데이트
외부 링크에 주의하세요.
외부 링크에 주의하세요.
자주 묻는 질문